Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T41646 | Target Info | |||
Target Name | Beta-arrestin-1 (ARRB1) | ||||
Synonyms | Non-visual arrestin-2; Betaarrestin1; Arrestin beta1; Arrestin beta-1; ARR1 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | ARRB1 | ||||
Biochemical Class | Arrestin protein | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
G-protein-coupled receptors | [+] 1 G-protein-coupled receptors | + | |||
Interacting Target Name | Adrenergic receptor beta-1 (ADRB1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Beta-1 adrenoreceptor; Beta-1 adrenoceptor; Beta-1 adrenergic receptor; B1AR; ADRB1R | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
Kinases | [+] 4 Kinases | + | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [3] | |||
2 | Protein-Fragment Complementation Assay | [3] | |||
3 | Yeast two hybrid | [4] | |||
Interacting Target Name | Apoptosis signal-regulating kinase 1 (MAP3K5) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Mitogen-activated protein kinase kinase kinase 5; MEKK5; MEKK 5; MEK kinase 5; MAPKKK5; MAPK/ERK kinase kinase 5; ASK-1; ASK1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Protein-peptide | [6] | |||
Interacting Target Name | Stress-activated protein kinase JNK3 (JNK3) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase 1b; SAPK1b; PRKM10; Mitogen-activated protein kinase 10; MAPK 10; MAP kinase p49 3F12; MAP kinase 10; JNK3A; C-Jun N-terminal kinase 3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Protein-peptide | [6] | |||
Interacting Protein Name | Phosphatidylinositol 3-kinase regulatory subunit beta (PIK3R2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MPPH; MPPH1; P85B; p85; p85.BETA | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Yeast two hybrid | [9] | |||
One-carbon transferases | [+] 1 One-carbon transferases | + | |||
Interacting Protein Name | Glycine N-methyltransferase (GNMT) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Yeast two hybrid | [10] | |||
3 | Yeast two hybrid | [9] | |||
Ubiquitin related proteins | [+] 1 Ubiquitin related proteins | + | |||
Interacting Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Yeast two hybrid | [12] | |||
Other proteins | [+] 5 Other proteins | + | |||
Interacting Protein Name | Nucleolar and coiled-body phosphoprotein 1 (NOLC1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NOPP130; NOPP140; NS5ATP13; P130 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Affinity Capture-MS | [13] | |||
3 | Affinity Capture-MS | [14] | |||
4 | Affinity Capture-Western | [8] | |||
Interacting Protein Name | Treacle protein (TCOF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MFD1; TCS; TCS1; treacle | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Affinity Capture-MS | [13] | |||
3 | Affinity Capture-MS | [14] | |||
4 | Affinity Capture-Western | [8] | |||
Interacting Protein Name | NF-kappa-B inhibitor alpha (NFKBIA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IKBA; MAD.3; NFKBI | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Affinity Capture-Western | [16] | |||
3 | Yeast two hybrid | [15] | |||
Interacting Protein Name | Zinc finger Ran-binding domain-containing protein 2 (ZRANB2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ZIS; ZIS1; ZIS2; ZNF265 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Affinity Capture-MS | [14] | |||
3 | Affinity Capture-Western | [8] | |||
Interacting Protein Name | Clathrin heavy chain 1 (CLTC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CHC; CHC17; CLH.17; CLTCL2; Hc | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Affinity Capture-Western | [17] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14555-60. | ||||
REF 2 | Interaction with beta-arrestin determines the difference in internalization behavor between beta1- and beta2-adrenergic receptors. J Biol Chem. 2000 Sep 15;275(37):29082-90. | ||||
REF 3 | The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92. | ||||
REF 4 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 5 | beta-Arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosis. Cell Signal. 2009 Jul;21(7):1195-206. | ||||
REF 6 | A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex. FEBS Lett. 2009 Oct 20;583(20):3310-6. | ||||
REF 7 | Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3. J Biol Chem. 2001 Jul 27;276(30):27770-7. | ||||
REF 8 | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12011-6. | ||||
REF 9 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 10 | Towards a proteome-scale map of the human protein-protein interaction network. Nature. 2005 Oct 20;437(7062):1173-8. | ||||
REF 11 | Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem. 2003 Mar 28;278(13):11648-53. | ||||
REF 12 | Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 2001 Nov 9;294(5545):1307-13. | ||||
REF 13 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 14 | Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol. 2007;3:89. | ||||
REF 15 | beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8603-7. | ||||
REF 16 | Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell. 2004 May 7;14(3):303-17. | ||||
REF 17 | Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. J Immunol. 2006 Jun 1;176(11):7039-50. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.